Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Periodontal Res ; 52(3): 582-593, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-27859260

RESUMO

BACKGROUND AND OBJECTIVES: The expression of A Disintegrin and Metalloproteinase 8 (ADAM8) is associated with several inflammatory diseases. Elevated ADAM8 levels have been shown in gingival crevicular fluid of patients with chronic periodontitis. The objective of this study was to investigate ADAM8 expression in chronic periodontitis tissues compared with that in normal tissues. ADAM8 expression and its inductive mechanism were examined in human gingival epithelial cells (HGECs) and human gingival fibroblasts. MATERIAL AND METHODS: Total RNA and protein were extracted from gingival biopsies of 33 patients with chronic periodontitis and those of 23 healthy volunteers. ADAM8 mRNA and protein expression was analyzed by real-time polymerase chain reaction, immunoblotting and immunohistochemistry. ADAM8 expression in control and stimulated cells in the presence or absence of specific inhibitors for mitogen-activated protein kinase pathways was assayed by real-time polymerase chain reaction, immunoblotting, flow cytometry and immunofluorescence. RESULTS: ADAM8 mRNA and protein expression in chronic periodontitis tissues was significantly greater than that in normal tissues (p < 0.01). Significantly increased ADAM8 expression was detected in the gingival epithelium of chronic periodontitis tissues (p < 0.001). ADAM8 mRNA expression in HGECs, but not in human gingival fibroblasts, was significantly induced by stimulation with Fusobacterium nucleatum (p < 0.05), partially via the p44/42 mitogen-activated protein kinase pathway. ADAM8 expression in the cell lysates and on the surface of HGECs was induced by stimulation with F. nucleatum. CONCLUSION: ADAM8 expression is increased in inflamed chronic periodontitis tissues and localized within gingival epithelium, consistent with an upregulation of ADAM8 expression in F. nucleatum-stimulated HGECs, suggesting a possible role of ADAM8 in innate immunity of periodontal tissue.


Assuntos
Proteínas ADAM/metabolismo , Periodontite Crônica/metabolismo , Células Epiteliais/metabolismo , Gengiva/metabolismo , Metaloproteinase 8 da Matriz/metabolismo , Proteínas de Membrana/metabolismo , Adulto , Western Blotting , Estudos de Casos e Controles , Citometria de Fluxo , Imunofluorescência , Gengiva/citologia , Humanos , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase em Tempo Real , Adulto Jovem
2.
J Periodontal Res ; 46(3): 327-37, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21338358

RESUMO

BACKGROUND AND OBJECTIVE: The antimicrobial peptide LL-37, derived from human neutrophils, can directly chemoattract leukocytes and up-regulate the expression of several immune-related genes in various cell types. In this study, we wanted to determine the immunoregulatory effect of LL-37 on interleukin-8 (IL-8) expression in human gingival fibroblasts (HGFs) and to characterize intracellular signaling pathway(s) and receptor(s) involved in IL-8 induction. MATERIAL AND METHODS: Cultured fibroblasts were treated with different concentrations of LL-37 or interleukin-1ß (IL-1ß), as a positive control, for specific periods of time in the presence or absence of various inhibitors. RT-PCR and real-time PCR were conducted to analyze the expression of IL-8 mRNA, and the IL-8 levels in cell-free culture media were measured using ELISAs. The MTT assay was performed to determine the cytotoxicity of LL-37. RESULTS: Nontoxic concentrations of LL-37 (up to 10 µm) and IL-1ß significantly up-regulated the expression of IL-8 mRNA in a dose-dependent manner (p < 0.05). The IL-8 protein levels were consistently significantly elevated in conditioned media of LL-37-treated HGFs (p < 0.05). IL-8 up-regulation by LL-37 was completely abrogated by 20 µm U0126, consistent with transient phosphorylation of p44/42 MAP kinases. Moreover, pretreatment with Brilliant Blue G (a selective antagonist of the P2X(7) receptor) and the neutralizing antibody against P2X(7) blocked IL-8 up-regulation in a dose-dependent manner, consistent with expression of the P2X(7) receptor in HGFs. CONCLUSION: These findings indicate that LL-37 induces IL-8 expression via the P2X(7) receptor and the MEK1/2-dependent p44/42 MAP kinases in HGFs, suggesting both direct and indirect involvement of LL-37 in neutrophil recruitment into an inflammatory site within diseased periodontal tissues.


Assuntos
Antibacterianos/farmacologia , Catelicidinas/farmacologia , Fibroblastos/efeitos dos fármacos , Gengiva/efeitos dos fármacos , Interleucina-8/efeitos dos fármacos , MAP Quinase Quinase 1/fisiologia , MAP Quinase Quinase 2/fisiologia , Receptores Purinérgicos P2X7/fisiologia , Regulação para Cima/efeitos dos fármacos , Anticorpos Neutralizantes/farmacologia , Peptídeos Catiônicos Antimicrobianos , Butadienos/farmacologia , Células Cultivadas , Meios de Cultura , Relação Dose-Resposta a Droga , Inibidores Enzimáticos/farmacologia , Gengiva/citologia , Humanos , Interleucina-1beta/farmacologia , Interleucina-8/metabolismo , MAP Quinase Quinase 1/antagonistas & inibidores , MAP Quinase Quinase 2/antagonistas & inibidores , Proteína Quinase 1 Ativada por Mitógeno/fisiologia , Proteína Quinase 3 Ativada por Mitógeno/fisiologia , Infiltração de Neutrófilos/fisiologia , Nitrilas/farmacologia , Fosforilação , Antagonistas do Receptor Purinérgico P2X/farmacologia , Corantes de Rosanilina/farmacologia
3.
J Periodontal Res ; 45(4): 464-70, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20337883

RESUMO

BACKGROUND AND OBJECTIVE: Oral epithelial cells express three antimicrobial peptide human beta-defensins (hBDs) that have previously been demonstrated to exert proinflammatory effects on various immune cells. We wanted to examine whether hBDs could induce cyclooxygenase-2 (COX-2) expression and prostaglandin E(2) (PGE(2)) synthesis in non-immune cells, such as human gingival fibroblasts. MATERIAL AND METHODS: Cultured fibroblasts were treated with different concentrations of hBD-1, -2, -3 or interleukin-1 beta, as a positive control, for various times, in the presence or absence of NS-398, a specific COX-2 inhibitor. The levels of COX-1 and COX-2 mRNA expression were analyzed using RT-PCR and real-time PCR. Whole cell lysates were analyzed for COX-1 and COX-2 protein expression by western blotting. Cell-free culture supernatants were assayed for PGE(2) levels by ELISA. The lactate dehydrogenase assay was performed to determine the cytotoxicity of hBDs. RESULTS: Ten and 40 microg/mL of hBD-3 up-regulated COX-2 mRNA and protein expression, consistent with COX-2 up-regulation by interleukin-1 beta, whereas hBD-1 and hBD-2 did not. However, COX-1 mRNA and protein were constitutively expressed. The time-course study revealed that hBD-3 up-regulated COX-2 mRNA and protein expression at 6 and 12 h, respectively. Consistent with COX-2 up-regulation, 10 and 40 microg/mL of hBD-3 significantly increased PGE(2) levels in cell-free culture supernatants (p < 0.05), and this was inhibited by NS-398 in a dose-dependent manner. Neither of the hBD concentrations tested in this study was toxic to the cells. CONCLUSION: These findings indicate that epithelial human beta-defensin-3 functions as a proinflammatory mediator in controlling arachidonic acid metabolism in underlying fibroblasts.


Assuntos
Ciclo-Oxigenase 2/efeitos dos fármacos , Dinoprostona/metabolismo , Fibroblastos/efeitos dos fármacos , Gengiva/efeitos dos fármacos , Regulação para Cima/efeitos dos fármacos , beta-Defensinas/farmacologia , Técnicas de Cultura de Células , Células Cultivadas , Meios de Cultivo Condicionados , Ciclo-Oxigenase 1/análise , Ciclo-Oxigenase 1/efeitos dos fármacos , Ciclo-Oxigenase 2/análise , Inibidores de Ciclo-Oxigenase 2/farmacologia , Dinoprostona/análise , Relação Dose-Resposta a Droga , Gengiva/citologia , Humanos , Mediadores da Inflamação/farmacologia , Interleucina-1beta/farmacologia , L-Lactato Desidrogenase/análise , Nitrobenzenos/farmacologia , Sulfonamidas/farmacologia , Fatores de Tempo , beta-Defensinas/toxicidade
4.
J Dent Res ; 88(11): 1031-6, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19828892

RESUMO

Matrix metalloproteinase-9 (MMP-9) is important in the pathogenesis of periodontitis. Cytosolic phospholipase A(2)alpha (cPLA(2)alpha) is involved in MMP-9 up-regulation in human monocytes. We tested the hypothesis that cPLA(2)alpha also regulates MMP-9 induction by Fusobacterium nucleatum and by phorbol 12-myristate-13-acetate (PMA) in gingival epithelial cells. While PMA induced MMP-9 expression considerably, F. nucleatum did so moderately. This time-course study demonstrated that MMP-9 mRNA up-regulation occurred at 3 hours, whereas MMP-9 secretion and activity in cell-free supernatants occurred at 12 hours. cPLA(2)alpha mRNA was constitutively expressed in gingival epithelial cells. Transient activation of cPLA(2) by Ser505 phosphorylation was observed in the nuclei upon stimulation, suggesting its role as a transcription factor, while cPLA(2) protein expression remained unchanged. Induction of MMP-9 expression and activity was significantly inhibited by 1 muM of the specific cPLA(2)alpha inhibitor (P < 0.01). These findings demonstrate the involvement of cPLA(2)alpha in MMP-9 up-regulation.


Assuntos
Fusobacterium nucleatum/enzimologia , Gengiva/enzimologia , Fosfolipases A2 do Grupo IV/fisiologia , Metaloproteinase 9 da Matriz/metabolismo , Regulação para Cima/fisiologia , Carcinógenos/farmacologia , Núcleo Celular/enzimologia , Células Cultivadas , Ativação Enzimática , Indução Enzimática/fisiologia , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/enzimologia , Células Epiteliais/microbiologia , Regulação Bacteriana da Expressão Gênica , Regulação Enzimológica da Expressão Gênica , Gengiva/citologia , Gengiva/efeitos dos fármacos , Gengiva/microbiologia , Fosfolipases A2 do Grupo IV/antagonistas & inibidores , Humanos , Fosforilação , Acetato de Tetradecanoilforbol/farmacologia , Fatores de Tempo , Fatores de Transcrição/fisiologia , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA